Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Harvard Business School
Boehringer Ingelheim
Colorcon
Express Scripts

Last Updated: January 26, 2023

CLINICAL TRIALS PROFILE FOR METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Metformin Hydrochloride; Saxagliptin Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00121641 ↗ Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Completed AstraZeneca Phase 3 2005-07-01 The purpose of this clinical research study is to learn whether saxagliptin (BMS-477118) is more effective than placebo as a treatment for type 2 diabetic subjects who are not sufficiently controlled with diet and exercise
NCT00121667 ↗ Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone Completed AstraZeneca Phase 3 2005-08-01 The purpose of this clinical research study is to learn whether Saxagliptin added to Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic subjects who are not sufficiently controlled with Metformin alone
NCT00327015 ↗ A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Completed AstraZeneca Phase 3 2006-05-01 The purpose of this trial is to understand if adding saxagliptin to metformin therapy is safe and works better than taking either saxagliptin or metformin alone
NCT00575588 ↗ 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period Completed Bristol-Myers Squibb Phase 3 2007-12-01 Saxagliptin is a new investigational medication being developed for treatment of type 2 diabetes. This study is designed to assess the efficacy and tolerability of saxagliptin in addition to metformin and compare to sulphonylurea in addition with metformin.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Metformin Hydrochloride; Saxagliptin Hydrochloride

Condition Name

Condition Name for Metformin Hydrochloride; Saxagliptin Hydrochloride
Intervention Trials
Type 2 Diabetes Mellitus 20
Type 2 Diabetes 16
Diabetes Mellitus, Type 2 8
Type2 Diabetes Mellitus 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Metformin Hydrochloride; Saxagliptin Hydrochloride
Intervention Trials
Diabetes Mellitus, Type 2 49
Diabetes Mellitus 47
Prediabetic State 2
Glucose Intolerance 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Metformin Hydrochloride; Saxagliptin Hydrochloride

Trials by Country

Trials by Country for Metformin Hydrochloride; Saxagliptin Hydrochloride
Location Trials
United States 295
Mexico 54
Canada 50
China 43
United Kingdom 38
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Metformin Hydrochloride; Saxagliptin Hydrochloride
Location Trials
Texas 23
California 18
Florida 16
Ohio 13
Tennessee 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Metformin Hydrochloride; Saxagliptin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Metformin Hydrochloride; Saxagliptin Hydrochloride
Clinical Trial Phase Trials
Phase 4 16
Phase 3 26
Phase 2 1
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Metformin Hydrochloride; Saxagliptin Hydrochloride
Clinical Trial Phase Trials
Completed 45
Unknown status 7
Recruiting 5
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Metformin Hydrochloride; Saxagliptin Hydrochloride

Sponsor Name

Sponsor Name for Metformin Hydrochloride; Saxagliptin Hydrochloride
Sponsor Trials
AstraZeneca 49
Bristol-Myers Squibb 10
The First Affiliated Hospital with Nanjing Medical University 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Metformin Hydrochloride; Saxagliptin Hydrochloride
Sponsor Trials
Industry 62
Other 41
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Baxter
McKinsey
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.